Pages that link to "Q36702385"
Jump to navigation
Jump to search
The following pages link to Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy. (Q36702385):
Displaying 11 items.
- Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer (Q33917578) (← links)
- Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer (Q36055084) (← links)
- Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel (Q37012053) (← links)
- High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma (Q37481225) (← links)
- Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes (Q37624199) (← links)
- Implications of functional proteomics in breast cancer (Q37698227) (← links)
- Proteomic analysis of tissue samples in translational breast cancer research. (Q38212502) (← links)
- Biomarkers of residual disease after neoadjuvant therapy for breast cancer (Q38726440) (← links)
- E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer (Q58603744) (← links)
- Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives (Q64107259) (← links)
- Profiling of Invasive Breast Carcinoma Circulating Tumour Cells-Are We Ready for the 'Liquid' Revolution? (Q64243735) (← links)